Trial Profile
Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China Correlation Between Recurrence and Drug Withdrawl
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Jun 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Bone cancer; Giant cell tumours
- Focus Therapeutic Use
- 05 Dec 2017 New trial record